Counselors in Mahtomedi, MN Accepting Medicare

5 Counselors found. Showing 1 - 5

Virginia Fitch-braun Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 760 Stillwater Rd Suite 101, Mahtomedi, MN 55115 Phone: 651-800-1159

Jean Marie Plattner, LADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 140 Quail St, Mahtomedi, MN 55115 Phone: 612-454-2469

Mr. Steve Donald Herrick, LADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 140 Quail St, Mahtomedi, MN 55115 Phone: 612-454-2468    Fax: 651-459-2677

Kelly Norris Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 760 Stillwater Rd Ste 101, Mahtomedi, MN 55115 Phone: 651-760-0866

Nancy Skilbred Counselor Medicare: Not Enrolled in Medicare Practice Location: 752 Stillwater Rd, Mahtomedi, MN 55115 Phone: 651-243-2484    Fax: 651-925-0045

News Archive

Bayer announces FDA acceptance of BAY 81-8973 BLA for treatment of hemophilia A

Bayer HealthCare today announced that the U.S. Food and Drug Administration has accepted the company's Biologics License Application for BAY 81-8973, a recombinant Factor VIII compound. Bayer is seeking FDA approval of the investigational compound, proposed trade name Kovaltry, for the treatment of hemophilia A in children and adults.

Hint of survival benefit with bevacizumabpemetrexed maintenance for NSCLC

Updated data from the phase III AVAPERL trial hint that there might be an overall survival benefit of using bevacizumab in combination with pemetrexed as maintenance therapy in patients with advanced nonsmall cell lung cancer.

SpinalMotion submits Kineflex lumbar artificial disc PMA to FDA

SpinalMotion, developer of the investigational Kineflex® lumbar and Kineflex/C® cervical disc implants for treating patients with degenerative disc disease (DDD), today reported that it has submitted the Pre-Market Approval (PMA) to FDA for the Kineflex lumbar artificial disc

Researchers use human stem cell models to analyze degeneration in glaucoma

More than 3 million Americans have glaucoma, a serious eye condition causing vision loss. Using human stem cell models, researchers at Indiana University School of Medicine found they could analyze deficits within cells damaged by glaucoma, with the potential to use this information to develop new strategies to slow the disease process.

Read more Medical News

› Verified 7 days ago